albendazole has been researched along with Koch's Disease in 4 studies
| Excerpt | Relevance | Reference |
|---|---|---|
| "The albendazole-treated group showed a decline in eosinophil cells (P=0." | 6.80 | Effects of albendazole on the clinical outcome and immunological responses in helminth co-infected tuberculosis patients: a double blind randomised clinical trial. ( Abate, E; Alemu, S; Aseffa, A; Britton, S; Diro, E; Elias, D; Getachew, A; Schön, T; Stendahl, O, 2015) |
| "The albendazole-treated group showed a decline in eosinophil cells (P=0." | 2.80 | Effects of albendazole on the clinical outcome and immunological responses in helminth co-infected tuberculosis patients: a double blind randomised clinical trial. ( Abate, E; Alemu, S; Aseffa, A; Britton, S; Diro, E; Elias, D; Getachew, A; Schön, T; Stendahl, O, 2015) |
| "Albendazole did not cause a change in TST size (P = 0." | 2.75 | Tuberculin skin-test reactions are unaffected by the severity of hyperendemic intestinal helminth infections and co-infections. ( Evans, CA; Garcia, HH; Vergara, A; Vergara, KC; Vidal, C; Zevallos, K, 2010) |
| "Tuberculosis was suspected but mycobacterial cultures remained negative." | 1.37 | Hepatic and pulmonary cystic echinococcosis in a patient from the Central African Republic. ( Bazelly, B; Brian, E; Develoux, M; Enache-Angoulvant, A; Gounant, V; Hennequin, C; Khalil, A, 2011) |
| "Both cystic echinococcosis (CE) and tuberculosis (Tbc) are important health problems in developing countries." | 1.37 | [Cystic echinococcosis mimicking tuberculosis in childhood]. ( Cobanoğlu, N; Doğru, D; Kiper, N; Köse, M; Ozçelik, U; Pekcan, S; Yalçın, E, 2011) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 4 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Abate, E | 1 |
| Elias, D | 1 |
| Getachew, A | 1 |
| Alemu, S | 1 |
| Diro, E | 1 |
| Britton, S | 1 |
| Aseffa, A | 1 |
| Stendahl, O | 1 |
| Schön, T | 1 |
| Zevallos, K | 1 |
| Vergara, KC | 1 |
| Vergara, A | 1 |
| Vidal, C | 1 |
| Garcia, HH | 1 |
| Evans, CA | 1 |
| Develoux, M | 1 |
| Enache-Angoulvant, A | 1 |
| Gounant, V | 1 |
| Brian, E | 1 |
| Khalil, A | 1 |
| Bazelly, B | 1 |
| Hennequin, C | 1 |
| Pekcan, S | 1 |
| Kiper, N | 1 |
| Köse, M | 1 |
| Cobanoğlu, N | 1 |
| Yalçın, E | 1 |
| Doğru, D | 1 |
| Ozçelik, U | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| The Impact of Deworming on Host Immunity and Clinical Outcome in Patients With Pulmonary Tuberculosis[NCT00857116] | 140 participants (Actual) | Interventional | 2009-03-31 | Completed | |||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
2 trials available for albendazole and Koch's Disease
| Article | Year |
|---|---|
Effects of albendazole on the clinical outcome and immunological responses in helminth co-infected tuberculosis patients: a double blind randomised clinical trial.
Topics: Adolescent; Adult; Albendazole; Anthelmintics; Body Weight; CD4-Positive T-Lymphocytes; Cytokines; D | 2015 |
Tuberculin skin-test reactions are unaffected by the severity of hyperendemic intestinal helminth infections and co-infections.
Topics: Adult; Albendazole; Anthelmintics; Double-Blind Method; Endemic Diseases; Feces; Female; Helminthias | 2010 |
2 other studies available for albendazole and Koch's Disease
| Article | Year |
|---|---|
Hepatic and pulmonary cystic echinococcosis in a patient from the Central African Republic.
Topics: Adult; Albendazole; Animals; Anticestodal Agents; Central African Republic; Diagnosis, Differential; | 2011 |
[Cystic echinococcosis mimicking tuberculosis in childhood].
Topics: Albendazole; Anthelmintics; Antitubercular Agents; Bronchoalveolar Lavage; Bronchoscopy; Child; Diag | 2011 |